Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
312.166019468
InChI
InChI=1S/C19H24N2S/c1-4-20(5-2)15(3)14-21-16-10-6-8-12-18(16)22-19-13-9-7-11-17(19)21/h6-13,15H,4-5,14H2,1-3H3
InChI Key
InChIKey=CDOZDBSBBXSXLB-UHFFFAOYSA-N
IUPAC Name
diethyl[1-(10H-phenothiazin-10-yl)propan-2-yl]amine
Traditional IUPAC Name
ethopropazine
SMILES
CCN(CC)C(C)CN1C2=CC=CC=C2SC2=CC=CC=C12
pKa (Strongest Basic)
9.6
Dược Lực Học :
Ethopropazine, a phenothiazine and antidyskinetic, is used in the treatment of Parkinson's disease. By improving muscle control and reducing stiffness, this drug permits more normal movements of the body as the disease symptoms are reduced. It is also used to control severe reactions to certain medicines such as reserpine, phenothiazines, chlorprothixene, thiothixene, loxapine, and haloperidol. Unlike other NMDA antagonists, ethopropazine — because of its anticholinergic action — is largely devoid of neurotoxic side effects. Ethopropazine also has a slight antihistaminic and local anesthetic effect.
Cơ Chế Tác Dụng :
Ethopropazine (also known as profenamine hydrochloride) is a medication derived from phenothiazine. It is primarily used as an antidyskinetic to treat parkinsonism. It is sold under the trade names Parsidol in the United States and Parsidan in Canada.
Ethopropazine's antiparkinson action can be attributed to its anticholinergic properties. Ethopropazine partially blocks central (striatal) cholinergic receptors, thereby helping to balance cholinergic and dopaminergic activity in the basal ganglia; salivation may be decreased, and smooth muscle may be relaxed. Drug-induced extrapyramidal symptoms and those due to parkinsonism may be relieved, but tardive dyskinesia is not alleviated and may be aggravated by anticholinergic effects. Ethopropazine's local anesthetic effect is due to its antagonism of the NMDA glutamate receptor. Glutamate is recognized as an important transmitter in nociceptive pathways, and the N-methyl-D-aspartate (NMDA) subtype of the glutamate receptor, in particular, has been implicated in the mediation of neuropathic pain. Excessive release of glutamate at NMDA receptors on dorsal horn neurons of the spinal cord results in hyperactivation and hypersensitivity of these receptors (perceived as hyperalgesia), thought to be an integral feature of neuropathic pain.
Dược Động Học :
▧ Absorption :
Well-absorbed from the gastrointestinal tract.
▧ Protein binding :
93%
▧ Half Life :
1 to 2 hours
Độc Tính :
Symptoms of overdose include severe clumsiness or unsteadiness, severe drowsiness, severe dryness of mouth, nose, or throat, fast heartbeat, shortness of breath or troubled breathing, and warmth, dryness, and flushing of skin.
Chỉ Định :
For use in the treatment of Parkinson's disease and also used to control severe reactions to certain medicines such as reserpine.
Tương Tác Thuốc :
-
Bromocriptine
The phenothiazine decreases the effect of bromocriptine
-
Cisapride
Increased risk of cardiotoxicity and arrhythmias
-
Dexfenfluramine
Decreased anorexic effect, may increase psychotic symptoms
-
Diethylpropion
Decreased anorexic effect, may increase psychotic symptoms
-
Donepezil
Possible antagonism of action
-
Fenfluramine
Decreased anorexic effect, may increase psychotic symptoms
-
Galantamine
Possible antagonism of action
-
Guanethidine
Ethopropazine may decrease the effect of guanethidine.
-
Haloperidol
The anticholinergic increases the risk of psychosis and tardive dyskinesia
-
Mazindol
Decreased anorexic effect, may increase psychotic symptoms
-
Phentermine
Decreased anorexic effect, may increase psychotic symptoms
-
Phenylpropanolamine
Decreased anorexic effect, may increase psychotic symptoms
Liều Lượng & Cách Dùng :
Tablet - Oral
Dữ Kiện Thương Mại
Giá thị trường
-
Giá bán buôn : USD >0.23
Đơn vị tính : tablet
Nhà Sản Xuất
-
Sản phẩm biệt dược : Dibutil
-
Sản phẩm biệt dược : Parkin
-
Sản phẩm biệt dược : Parsidan
-
Sản phẩm biệt dược : Parsidol